A week after 20,000 COVID-19 patients deemed at risk for progressing to a severe or life-threatening condition received plasma therapy, their risk of death dropped to 9%, compared to 12% in a previous study, Mayo Clinic researchers reported.The study included men and women, and significant numbers of patients who were Black, Hispanic or Asian.
"We're optimistic, but must remain objective as we assess increasing amounts of data," principal investigator Dr. Michael Joyner, a vice chairman for research at the Mayo Clinic in Rochester, Minn., said in a clinic news release. The researchers can't say for sure that the transfusions from recovered patients save lives. Joyner's team pointed out that the results might be due to patients being less ill, or to better medical care. But because the treatment is being widely used with COVID-19 patients, study continues.Plasma is the liquid part of the blood. It contains both red and white blood cells, as well as the colorless platelets the body deploys to clot and stem bleeding from wounds or cuts.
Ramosalberto01 También sería probable con ls que tienen linfocitos T, que no permiten intrusos en el organismo.
ShahiArif 'The researchers can't say for sure that the transfusions from recovered patients save lives. ' The plasma therapy hasn't proved to be statistically significant so far. More and more date need.
Is this why TraitorTrump hasn’t gotten sick?